These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30318307)

  • 1. Correlates of vaccine adjuvanticity, vaccine activity, protective immunity and disease in human infectious disease and cancer.
    Ottenhoff THM
    Semin Immunol; 2018 Oct; 39():1-3. PubMed ID: 30318307
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
    Ho NI; Huis In 't Veld LGM; Raaijmakers TK; Adema GJ
    Front Immunol; 2018; 9():2874. PubMed ID: 30619259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boosting vaccine power.
    Garçon N; Goldman M
    Sci Am; 2009 Oct; 301(4):72-9. PubMed ID: 19780455
    [No Abstract]   [Full Text] [Related]  

  • 4. Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.
    De Serrano LO; Burkhart DJ
    J Nanobiotechnology; 2017 Nov; 15(1):83. PubMed ID: 29149896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of GLA family adjuvants' activities.
    Reed SG; Carter D; Casper C; Duthie MS; Fox CB
    Semin Immunol; 2018 Oct; 39():22-29. PubMed ID: 30366662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 as an adjuvant for induction of protective antibody responses.
    Metzger DW
    Cytokine; 2010; 52(1-2):102-7. PubMed ID: 20650650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter from the editor.
    Ellis R; Riedmann EM
    Hum Vaccin Immunother; 2014; 10(7):1771-2. PubMed ID: 25424780
    [No Abstract]   [Full Text] [Related]  

  • 8. Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses.
    Clements JD; Freytag LC
    Clin Vaccine Immunol; 2016 Jun; 23(6):438-441. PubMed ID: 27122485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocorrelates of CAF family adjuvants.
    Pedersen GK; Andersen P; Christensen D
    Semin Immunol; 2018 Oct; 39():4-13. PubMed ID: 30396811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines and adjuvants--special issue.
    Robinson K; Oyston P
    J Med Microbiol; 2012 Jul; 61(Pt 7):887-888. PubMed ID: 22538995
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA vaccines: a ray of hope.
    Tuteja R
    Crit Rev Biochem Mol Biol; 1999; 34(1):1-24. PubMed ID: 10090468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice].
    Marelli P; Lupetti A; Senesi S; Uslenghi C; Girardello R; Campa M
    Drugs Exp Clin Res; 1993; 19 Suppl():15-21. PubMed ID: 8625778
    [No Abstract]   [Full Text] [Related]  

  • 13. Current adjuvants and new perspectives in vaccine formulation.
    Montomoli E; Piccirella S; Khadang B; Mennitto E; Camerini R; De Rosa A
    Expert Rev Vaccines; 2011 Jul; 10(7):1053-61. PubMed ID: 21806399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
    Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
    PLoS One; 2016; 11(3):e0150678. PubMed ID: 26930068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory properties of vitamins, flavonoids and plant oils and their potential as vaccine adjuvants and delivery systems.
    Vajdy M
    Expert Opin Biol Ther; 2011 Nov; 11(11):1501-13. PubMed ID: 21955085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiological interferons and their role in the body. I. Biological activities of interferons].
    Błach-Olszewska Z
    Postepy Hig Med Dosw; 1988; 42(3):260-95. PubMed ID: 3150039
    [No Abstract]   [Full Text] [Related]  

  • 17. The concept of vaccination failure.
    Heininger U; Bachtiar NS; Bahri P; Dana A; Dodoo A; Gidudu J; Santos EM
    Vaccine; 2012 Feb; 30(7):1265-8. PubMed ID: 22197579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Functional Properties of Neonatal Dendritic Cells: A Doorway to Enhance Vaccine Effectiveness?
    Papaioannou NE; Pasztoi M; Schraml BU
    Front Immunol; 2018; 9():3123. PubMed ID: 30687326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
    Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
    Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant.
    Maraskovsky E; Schnurr M; Wilson NS; Robson NC; Boyle J; Drane D
    Immunol Cell Biol; 2009 Jul; 87(5):371-6. PubMed ID: 19381160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.